Parkinson’s disease patients - 3 overnight stay at our clinic in Nottingham

QSC304540 Group 1
Overview

The test medicine is a new formulation combining opicapone with levodopa and carbidopa. The combination of opicapone, levodopa and carbidopa in a single dosage is hoped to make treatment simpler, helping patients stick to their medication routine, and giving more consistent relief from Parkinson’s symptoms. 

The medicine is already marketed in a different form.


Please note: Information correct at time of publisbhing but may be subject to final Ethics or MHRA approval and may change without notice. E&OE.

Payment
£2,285 - £2,345
plus 2 travel allowances
Volunteer profile
  • Males and Females
  • Aged 40 and over
  • BMI 18 - 35
  • Taking Sinemet Plus
  • Not suitable for Vegetarians
  • Suitable for smokers - You must not smoke for 24 hours prior to admission, and smoking will not be permitted at any time during your stay in the clinic
Schedule information
1
Screening Visit
Tuesday 5th January or Wednesday 6th January
An appointment with a doctor & nurse lasting approx. 4 hours
2
Residential visit - Admission PM - Discharge Lunchtime
Tuesday 19th January - Friday 22nd January 2027
3 overnight stay in our clinic
3
Follow up call
Thursday 28th January
A telephone appointment with a doctor & nurse
Ready to take part in a trial?
Apply today! Simply complete the online application form to become a volunteer.